newly diagnosed, non-metastatic, SHH-activated, TP53-wt, non-MYC amplified medulloblastoma research hub

Comparison of neurocognitive outcome in two standard regimen for treatment of low-risk medulloblastoma (COGNITO-MB)

This study compares different standard treatments for a type of childhood brain cancer called medulloblastoma. It looks at how these treatments affect children's thinking and learning abilities, also known as neurocognitive outcome, over time.